TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $688,848 | +8.7% | 44,528 | +10.4% | 0.00% | +50.0% |
| Q2 2023 | $633,757 | -6.7% | 40,341 | -2.1% | 0.00% | -33.3% |
| Q1 2023 | $678,959 | -9.1% | 41,199 | -9.7% | 0.00% | +50.0% |
| Q4 2022 | $746,760 | +1085.3% | 45,605 | +335.8% | 0.00% | – |
| Q2 2022 | $63,000 | -67.2% | 10,464 | -0.8% | 0.00% | -100.0% |
| Q4 2020 | $192,000 | -41.3% | 10,549 | -42.5% | 0.00% | -50.0% |
| Q3 2020 | $327,000 | -24.7% | 18,338 | -24.2% | 0.00% | 0.0% |
| Q2 2020 | $434,000 | +1.2% | 24,196 | -14.4% | 0.00% | -33.3% |
| Q1 2020 | $429,000 | -27.4% | 28,264 | -5.6% | 0.00% | 0.0% |
| Q4 2019 | $591,000 | +31.9% | 29,932 | +15.0% | 0.00% | +50.0% |
| Q3 2019 | $448,000 | -8.2% | 26,036 | -5.5% | 0.00% | -33.3% |
| Q2 2019 | $488,000 | -11.9% | 27,556 | +1.3% | 0.00% | 0.0% |
| Q1 2019 | $554,000 | – | 27,202 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |